1059535

Celgene Corporation — FEI 3004991673

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Summit, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)